Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...
Expansion microscopy helped researchers visualize Plasmodium inside near-intact mosquitoes, preserving anatomical context for ...
German chemical and materials manufacturing company Covestro is addressing the environmental impact of aniline, a substance used in the production of synthetic indigo dye. The company announced the ...
Apple is no longer the dominant player in smartphones, or at least the brand that restricted and built walls around its ecosystem and allowed nobody into its ecosystem. But that is now changing ...
Northwestern Medicine scientists have developed a new experimental method to analyze conformational fluctuations in protein domains on a uniquely large scale, which may improve data-driven modeling, ...
This repository contains the source code for Biocontrol_modeling_project, developed by César Augusto García Echeverry at the Laboratory of Software Development for Process Control and Optimization ...
Editor’s note: The story was updated to clarify Daniel and Rebecca Yarnie’s connection with Polar Views LLC based on official documents. Two developers behind several housing projects in Worcester ...
The Center for Coastal Climate Resilience (CCCR) at the University of California, Santa Cruz, has partnered with The Nature Conservancy to develop a new tool for funding wetland conservation and ...
An aerial view of marshes on Bair Island in San Francisco Bay in front of the low-lying homes and businesses of the Redwood Shores community. The Center for Coastal Climate Resilience (CCCR) at the ...
AI powerhouse Anthropic is continuing its push into the healthcare arena with the acquisition of previously stealth AI biotech startup Coefficient Bio in a $400 million stock deal, according to ...
Of all the characters in Project Hail Mary, none are as enigmatic as Eva Stratt. The head of the Petrova Taskforce — the international team trying to save humanity after the Sun begins to dim — has ...
On March 20, 2026, Accord, Intas, and Bio-Thera Solutions filed four petitions for inter partes review (“IPR”) challenging Janssen patents related to Simponi ® (golimumab). The petitions are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results